Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
ID | DOID:50918 |
Name | vaginal carcinoma |
Definition | A vaginal cancer that has_material_basis_in epithelial cells. |
Source | DiseaseOntology.org |
Alt Ids | |
Path | disease disease of cellular proliferation cancer organ system cancer reproductive organ cancer female reproductive organ cancer vaginal cancer vaginal carcinoma |
Molecular Profile | Therapy | Indication/Tumor Type | Response Type | Profile Response Detail |
---|---|---|---|---|
RET fusion | Selpercatinib | vaginal carcinoma | sensitive | detail... |
MLH1 negative | Pembrolizumab | vaginal carcinoma | sensitive | detail... |
MSH6 negative | Pembrolizumab | vaginal carcinoma | sensitive | detail... |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02834013 | Phase 0 | Ipilimumab + Nivolumab | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors | Active, not recruiting | USA | 1 |
NCT03345784 | Phase I | Adavosertib + Cisplatin | WEE1 Inhibitor AZD1775, External Beam Radiation Therapy, and Cisplatin in Treating Patients With Cervical, Vaginal, or Uterine Cancer | Terminated | USA | CAN | 0 |
NCT03418480 | Phase Ib/II | BNT113 | HPV Anti-CD40 RNA Vaccine (HARE-40) | Completed | GBR | 0 |